The Current Ratio as of November 2024 (TTM) for Alzamend Neuro, Inc. (ALZN) is 0.49

According to Alzamend Neuro, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.49. This represents a change of 96.37% compared to the average of 0.25 of the last 4 quarters.

Alzamend Neuro, Inc. (ALZN) Historical Current Ratio (quarterly & annually)

How has ALZN Current Ratio performed in the past?

The mean historical Current Ratio of Alzamend Neuro, Inc. over the last ten years is 5.12. The current 0.49 Current Ratio has changed 858.83% with respect to the historical average. Over the past ten years (40 quarters), ALZN's Current Ratio was at its highest in in the January 2022 quarter at 26.62. The Current Ratio was at its lowest in in the January 2001 quarter at 0.

Alzamend Neuro, Inc. (ALZN) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Alzamend Neuro, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Alzamend Neuro, Inc. (ALZN) Average Current Ratio

How has ALZN Current Ratio performed in the past?

The current Current Ratio of Alzamend Neuro, Inc. (ALZN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Alzamend Neuro, Inc. (ALZN) Current Ratio vs. Peers

How is ALZN’s Current Ratio compared to its peers?

Alzamend Neuro, Inc.’s Current Ratio is less than TRACON Pharmaceuticals, Inc. (0.66), less than Solid Biosciences Inc. (13.45), less than Kezar Life Sciences, Inc. (9.58), less than Senti Biosciences, Inc. (4.89), less than X4 Pharmaceuticals, Inc. (0), less than Inozyme Pharma, Inc. (6.07), less than Terns Pharmaceuticals, Inc. (9.84), less than Day One Biopharmaceuticals, Inc. (21.02), less than HOOKIPA Pharma Inc. (14.62), less than Acumen Pharmaceuticals, Inc. (3.86), less than VectivBio Holding AG (17.37), less than Molecular Partners AG (9.14), less than Adverum Biotechnologies, Inc. (14.58), less than Alector, Inc. (7.99), less than Adagene Inc. (3.52), less than null (2.50),

Build a custom stock screener for Alzamend Neuro, Inc. (ALZN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Alzamend Neuro, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Alzamend Neuro, Inc. (ALZN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Alzamend Neuro, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.